Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
申请人:Novo Nordisk A/S
公开号:US06248781B1
公开(公告)日:2001-06-19
The present invention relates to compounds of formula (I)
wherein R1, R2, R3, R4, R5, R6, R7, R8, Ar, X, Q, A, Y and Z are as defined in the specification. These compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
本发明涉及式(I)的化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、Ar、X、Q、A、Y和Z如规范中所定义。这些化合物在治疗和/或预防由核受体介导的疾病中具有用途,特别是过氧化物酶体增殖激活受体(PPAR)。